EGEN-5784

N/A

Report date: 2026/05/08 20:02:52

Base Information

Drug NameEGEN-5784
Drug Alias NameGenetically engineered porcine liver (Egenesis)EGEN-5784
ClassificationBiologicsCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcute-On-Chronic Liver FailureHepatic Encephalopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEgenesis Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrganox LtdEgenesis Inc
Inactive CompaniesN/A
Active IndicationsAcute-On-Chronic Liver FailureHepatic Encephalopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A